FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 349

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
CRIS Nasdaq Curis, Inc. 2836
CRNX Nasdaq Crinetics Pharmaceuticals, Inc. 2836
CRSP Nasdaq CRISPR Therapeutics AG 2836
CRVO Nasdaq CervoMed Inc. 2836
CSCI Nasdaq COSCIENS Biopharma Inc. 2836
CSLLY Over the counter CSL Limited 2836
CTCX Nasdaq Carmell Corporation 2836
CVAC Nasdaq CureVac N.V. 2836
CVM NYSE American CEL-SCI Corporation 2836
CYCC Nasdaq Cyclacel Pharmaceuticals, Inc. 2836
DAWN Nasdaq Day One Biopharmaceuticals, Inc. 2836
DCTH Nasdaq Delcath Systems, Inc. 2836
DMAC Nasdaq DiaMedica Therapeutics Inc. 2836
DNA New York Ginkgo Bioworks Holdings, Inc. 2836
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRMA Nasdaq Dermata Therapeutics, Inc. 2836
DRRX Nasdaq DURECT Corporation 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DTIL Nasdaq Precision BioSciences, Inc. 2836
DVAX Nasdaq Dynavax Technologies Corporation 2836
DYAI Nasdaq Dyadic International, Inc. 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
EDIT Nasdaq Editas Medicine, Inc. 2836
EDSA Nasdaq Edesa Biotech, Inc. 2836
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2836
ELEV Nasdaq Elevation Oncology, Inc. 2836
ELTX Nasdaq Elicio Therapeutics, Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ENGN Nasdaq enGene Holdings Inc. 2836
ENSC Nasdaq Ensysce Biosciences, Inc. 2836
ENTO Nasdaq Entero Therapeutics, Inc. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
ENVB Nasdaq Enveric Biosciences, Inc. 2836
EQ Nasdaq Equillium, Inc. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Eterna Therapeutics Inc. 2836
ESLA Nasdaq Estrella Immunopharma, Inc. 2836
EVGN Nasdaq Evogene Ltd. 2836
EXAS Nasdaq Exact Sciences Corporation 2836
FBLG Nasdaq FibroBiologics, Inc. 2836
FBRX Nasdaq Forte Biosciences, Inc. 2836
FDMT Nasdaq 4D Molecular Therapeutics, Inc. 2836
FNCH Over the counter Finch Therapeutics Group, Inc. 2836
GANX Nasdaq Gain Therapeutics, Inc. 2836
GDTC Nasdaq CytoMed Therapeutics Limited 2836
GELS Nasdaq Gelteq Limited 2836
GERN Nasdaq Geron Corporation 2836
GILD Nasdaq Gilead Sciences, Inc. 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
Results 100 through 150 of 349